Red man syndrome - Revision history

Danbot: Danbot moved page Red Man Syndrome to Red man syndrome: Naming convention: first word capitalized, subsequent words lowercase

2026-03-22T05:38:37Z

Danbot moved page Red Man Syndrome to Red man syndrome: Naming convention: first word capitalized, subsequent words lowercase

← Older revision	Revision as of 05:38, 22 March 2026
(No difference)

Ostermayer at 13:55, 30 August 2025

2025-08-30T13:55:04Z

← Older revision		Revision as of 13:55, 30 August 2025
Line 5:		Line 5:

	===Epidemiology===		===Epidemiology===
	RMS occurs in up to 50% of patients receiving rapid vancomycin infusions, but the incidence drops to <5% with proper slow administration. It is more common in adults than children and does not correlate with vancomycin serum levels.<ref>Wallace MR, Mascola JR, Oldfield EC 3rd. Red man syndrome: incidence, etiology, and prophylaxis. Journal of Infectious Diseases. 1991;164(6):1180-1185. ~~(An early review examining incidence rates, causative factors, and preventive measures.)~~</ref>		RMS occurs in up to 50% of patients receiving rapid vancomycin infusions, but the incidence drops to <5% with proper slow administration. It is more common in adults than children and does not correlate with vancomycin serum levels.<ref>Wallace MR, Mascola JR, Oldfield EC 3rd. Red man syndrome: incidence, etiology, and prophylaxis. Journal of Infectious Diseases. 1991;164(6):1180-1185. </ref>

	===History===		===History===
Line 18:		Line 18:
	* Rarely, more severe manifestations like angioedema or bronchospasm.		* Rarely, more severe manifestations like angioedema or bronchospasm.

	Symptoms usually begin within 4-10 minutes of starting the infusion and can last from 20 minutes to several hours, depending on the infusion rate and dose.<ref>Lutomski DM, Lafollette JA, Biaglow MA, et al. Antibiotic hypersensitivity in the intensive care unit. Journal of Intensive Care Medicine. 2008;23(6):409-421. ~~(Broader review including Red Man Syndrome as a key example of infusion-related reactions.)~~</ref>		Symptoms usually begin within 4-10 minutes of starting the infusion and can last from 20 minutes to several hours, depending on the infusion rate and dose.<ref>Lutomski DM, Lafollette JA, Biaglow MA, et al. Antibiotic hypersensitivity in the intensive care unit. Journal of Intensive Care Medicine. 2008;23(6):409-421.</ref>

	== Causes ==		== Causes ==

Ostermayer: /* Treatment */

2025-08-30T13:53:26Z

Treatment

← Older revision		Revision as of 13:53, 30 August 2025
Line 40:		Line 40:
	Management is supportive and focuses on alleviating symptoms:		Management is supportive and focuses on alleviating symptoms:
	* Immediately slow or stop the vancomycin infusion.		* Immediately slow or stop the vancomycin infusion.
	* Administer antihistamines (e.g., [[diphenhydramine]] 25-50 mg IV) to block histamine effects.		* Administer antihistamines (e.g., [[diphenhydramine]] 25-50 mg IV) to block histamine effects.<ref>Renz CL, Thurn JD, Finn HA, et al. Oral antihistamines reduce the severity of anaphylactoid reactions to vancomycin. Anesthesia & Analgesia. 1999;88(2):434-438.</ref>
	* For hypotension, provide IV fluids and, if severe, vasopressors.		* For hypotension, provide IV fluids and, if severe, vasopressors.
	* In rare severe cases, corticosteroids or epinephrine may be used, though this is uncommon.		* In rare severe cases, corticosteroids or epinephrine may be used, though this is uncommon.

Ostermayer: /* Mechanism */

2025-08-30T13:51:46Z

Mechanism

← Older revision		Revision as of 13:51, 30 August 2025
Line 27:		Line 27:

	== Mechanism ==		== Mechanism ==
	RMS results from non-immunologic mast cell degranulation, leading to the release of histamine and other vasoactive mediators. Vancomycin directly stimulates mast cells and basophils, causing histamine release without involving IgE antibodies. This distinguishes it from true anaphylaxis. The reaction is more pronounced with impure or older formulations of vancomycin, though modern preparations have reduced incidence.		RMS results from non-immunologic mast cell degranulation, leading to the release of histamine and other vasoactive mediators. Vancomycin directly stimulates mast cells and basophils, causing histamine release without involving IgE antibodies. This distinguishes it from true anaphylaxis. The reaction is more pronounced with impure or older formulations of vancomycin, though modern preparations have reduced incidence.<ref>Healy DP, Sahai JV, Fuller SH, et al. Vancomycin-induced histamine release and "red man syndrome": comparison of 1- and 2-hour rapid infusion regimens in normal volunteers. Antimicrobial Agents and Chemotherapy. 1990;34(4):550-554. </ref>

	== Diagnosis ==		== Diagnosis ==

Ostermayer: /* Signs and symptoms */

2025-08-30T13:51:15Z

Signs and symptoms

← Older revision		Revision as of 13:51, 30 August 2025
Line 18:		Line 18:
	* Rarely, more severe manifestations like angioedema or bronchospasm.		* Rarely, more severe manifestations like angioedema or bronchospasm.

	Symptoms usually begin within 4-10 minutes of starting the infusion and can last from 20 minutes to several hours, depending on the infusion rate and dose.		Symptoms usually begin within 4-10 minutes of starting the infusion and can last from 20 minutes to several hours, depending on the infusion rate and dose.<ref>Lutomski DM, Lafollette JA, Biaglow MA, et al. Antibiotic hypersensitivity in the intensive care unit. Journal of Intensive Care Medicine. 2008;23(6):409-421. (Broader review including Red Man Syndrome as a key example of infusion-related reactions.)</ref>

	== Causes ==		== Causes ==

Ostermayer: /* Background */

2025-08-30T13:50:40Z

Background

← Older revision		Revision as of 13:50, 30 August 2025
Line 2:		Line 2:

	'''Red man syndrome''' (RMS) is an adverse reaction associated with the rapid intravenous (IV) infusion of [[vancomycin]], a [[glycopeptide]]. It is characterized by flushing, erythema (redness), and pruritus (itching) primarily affecting the upper body, often the face, neck, and torso—hence the name. RMS is not a true allergic reaction but rather an anaphylactoid response mediated by histamine release from mast cells. It typically occurs during or shortly after infusion and resolves quickly once the infusion is slowed or stopped. Similar reactions can occur with other glycopeptides like [[teicoplanin]], though less commonly.		'''Red man syndrome''' (RMS) is an adverse reaction associated with the rapid intravenous (IV) infusion of [[vancomycin]], a [[glycopeptide]]. It is characterized by flushing, erythema (redness), and pruritus (itching) primarily affecting the upper body, often the face, neck, and torso—hence the name. RMS is not a true allergic reaction but rather an anaphylactoid response mediated by histamine release from mast cells. It typically occurs during or shortly after infusion and resolves quickly once the infusion is slowed or stopped. Similar reactions can occur with other glycopeptides like [[teicoplanin]], though less commonly.


			===Epidemiology===
			RMS occurs in up to 50% of patients receiving rapid vancomycin infusions, but the incidence drops to <5% with proper slow administration. It is more common in adults than children and does not correlate with vancomycin serum levels.<ref>Wallace MR, Mascola JR, Oldfield EC 3rd. Red man syndrome: incidence, etiology, and prophylaxis. Journal of Infectious Diseases. 1991;164(6):1180-1185. (An early review examining incidence rates, causative factors, and preventive measures.)</ref>

			===History===
			The syndrome was first described in the 1950s following the introduction of vancomycin. Initially termed "red neck syndrome," it was linked to impurities in early vancomycin batches. Advances in purification have reduced its frequency, but it remains a notable adverse effect.<ref>Sivagnanam S, Deleu D. Red man syndrome. Critical Care. 2003;7(2):119-120. (A concise review focusing on pathophysiology, clinical features, and management strategies.</ref>

	== Signs and symptoms ==		== Signs and symptoms ==

Ostermayer at 13:49, 30 August 2025

2025-08-30T13:49:40Z

← Older revision		Revision as of 13:49, 30 August 2025
Line 45:		Line 45:
	* Using alternative antibiotics if repeated reactions occur, though desensitization protocols exist for necessary vancomycin use.		* Using alternative antibiotics if repeated reactions occur, though desensitization protocols exist for necessary vancomycin use.

	~~== Epidemiology ==~~
	RMS occurs in up to 50% of patients receiving rapid vancomycin infusions, but the incidence drops to <5% with proper slow administration. It is more common in adults than children and does not correlate with vancomycin serum levels.

	~~== History ==~~
	The syndrome was first described in the 1950s following the introduction of vancomycin. Initially termed "red neck syndrome," it was linked to impurities in early vancomycin batches. Advances in purification have reduced its frequency, but it remains a notable adverse effect.<ref>Sivagnanam S, Deleu D. Red man syndrome. Critical Care. 2003;7(2):119-120. (A concise review focusing on pathophysiology, clinical features, and management strategies.</ref>

	== See also ==		== See also ==

Ostermayer: /* History */

2025-08-30T13:49:11Z

History

← Older revision		Revision as of 13:49, 30 August 2025
Line 49:		Line 49:

	== History ==		== History ==
	The syndrome was first described in the 1950s following the introduction of vancomycin. Initially termed "red neck syndrome," it was linked to impurities in early vancomycin batches. Advances in purification have reduced its frequency, but it remains a notable adverse effect.		The syndrome was first described in the 1950s following the introduction of vancomycin. Initially termed "red neck syndrome," it was linked to impurities in early vancomycin batches. Advances in purification have reduced its frequency, but it remains a notable adverse effect.<ref>Sivagnanam S, Deleu D. Red man syndrome. Critical Care. 2003;7(2):119-120. (A concise review focusing on pathophysiology, clinical features, and management strategies.</ref>

	== See also ==		== See also ==

Ostermayer: Created page with "==Background== '''Red man syndrome''' (RMS) is an adverse reaction associated with the rapid intravenous (IV) infusion of vancomycin, a glycopeptide. It is characterized by flushing, erythema (redness), and pruritus (itching) primarily affecting the upper body, often the face, neck, and torso—hence the name. RMS is not a true allergic reaction but rather an anaphylactoid response mediated by histamine release from mast cells. It typically occurs during or shor..."

2025-08-30T12:55:46Z

Created page with "==Background== '''Red man syndrome''' (RMS) is an adverse reaction associated with the rapid intravenous (IV) infusion of vancomycin, a glycopeptide. It is characterized by flushing, erythema (redness), and pruritus (itching) primarily affecting the upper body, often the face, neck, and torso—hence the name. RMS is not a true allergic reaction but rather an anaphylactoid response mediated by histamine release from mast cells. It typically occurs during or shor..."

New page

==Background==

'''Red man syndrome''' (RMS) is an adverse reaction associated with the rapid intravenous (IV) infusion of [[vancomycin]], a [[glycopeptide]]. It is characterized by flushing, erythema (redness), and pruritus (itching) primarily affecting the upper body, often the face, neck, and torso—hence the name. RMS is not a true allergic reaction but rather an anaphylactoid response mediated by histamine release from mast cells. It typically occurs during or shortly after infusion and resolves quickly once the infusion is slowed or stopped. Similar reactions can occur with other glycopeptides like [[teicoplanin]], though less commonly.

== Signs and symptoms ==
The hallmark symptoms of red man syndrome include:
* Intense flushing and erythema of the face, neck, upper chest, and arms (resembling a severe sunburn).
* Pruritus (itching), which can be widespread.
* Hypotension (low blood pressure), which may lead to dizziness or fainting.
* Tachycardia (rapid heart rate) and, in severe cases, chest pain or dyspnea (shortness of breath).
* Rarely, more severe manifestations like angioedema or bronchospasm.

Symptoms usually begin within 4-10 minutes of starting the infusion and can last from 20 minutes to several hours, depending on the infusion rate and dose.

== Causes ==
Red man syndrome is primarily caused by the rapid IV administration of vancomycin. The reaction is dose- and rate-dependent:
* Higher doses (e.g., >500 mg) or rapid infusion (e.g., over less than 60 minutes) increase the risk.
* It may also occur with other drugs that trigger mast cell degranulation, such as certain opioids (e.g., morphine) or contrast media.
* Risk factors include a history of previous RMS episodes, atopic conditions, or concurrent use of drugs that enhance histamine release.

== Mechanism ==
RMS results from non-immunologic mast cell degranulation, leading to the release of histamine and other vasoactive mediators. Vancomycin directly stimulates mast cells and basophils, causing histamine release without involving IgE antibodies. This distinguishes it from true anaphylaxis. The reaction is more pronounced with impure or older formulations of vancomycin, though modern preparations have reduced incidence.

== Diagnosis ==
Diagnosis is primarily clinical, based on the timing and symptoms during vancomycin infusion. It is differentiated from true vancomycin allergy (which involves IgE-mediated hypersensitivity) by:
* Lack of urticaria or systemic involvement in mild cases.
* Resolution upon slowing the infusion, without need for epinephrine.
* Negative skin testing for allergy.

Monitoring vital signs during infusion can aid in early detection.

== Treatment ==
Management is supportive and focuses on alleviating symptoms:
* Immediately slow or stop the vancomycin infusion.
* Administer antihistamines (e.g., [[diphenhydramine]] 25-50 mg IV) to block histamine effects.
* For hypotension, provide IV fluids and, if severe, vasopressors.
* In rare severe cases, corticosteroids or epinephrine may be used, though this is uncommon.

Most episodes resolve without long-term sequelae.

== Prevention ==
Preventive measures include:
* Infusing vancomycin slowly: At least 60 minutes for 1 g, or longer for higher doses (e.g., 2 hours for 2 g).
* Premedication with antihistamines (e.g., diphenhydramine) and/or H2 blockers (e.g., ranitidine) for patients with prior RMS.
* Using alternative antibiotics if repeated reactions occur, though desensitization protocols exist for necessary vancomycin use.

== Epidemiology ==
RMS occurs in up to 50% of patients receiving rapid vancomycin infusions, but the incidence drops to <5% with proper slow administration. It is more common in adults than children and does not correlate with vancomycin serum levels.

== History ==
The syndrome was first described in the 1950s following the introduction of vancomycin. Initially termed "red neck syndrome," it was linked to impurities in early vancomycin batches. Advances in purification have reduced its frequency, but it remains a notable adverse effect.

== See also ==
* [[Vancomycin]]

== References ==
<references/>

[[Category:Pharmacology]]